Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafaela Lacerda

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biomedicines|August 26, 2022
Internal Ribosome Entry Site (IRES)-Mediated Translation and Its Potential for Novel mRNA-Based Therapy DevelopmentRita Marques, Rafaela Lacerda, Luísa Romão
Journal of Molecular Biology|July 13, 2026
DIS3L2 and nonsense-mediated decay: united to degradeRafaela Lacerda, Miguel Carvalho, Luísa Romão
Cellular and Molecular Life Sciences : CMLS|December 4, 2016
More than just scanning: the importance of cap-independent mRNA translation initiation for cellular stress response and cancerRafaela Lacerda, Juliane Menezes, Luísa Romão
Advances in Experimental Medicine and Biology|July 26, 2019
Alternative Mechanisms of mRNA Translation Initiation in Cellular Stress Response and CancerRafaela Lacerda, Juliane Menezes, Marco M Candeias
RNA Biology|November 4, 2017
eIF3: a factor for human health and diseaseAndreia Gomes-Duarte, Rafaela Lacerda, Juliane Menezes, et al.
RNA (New York, N.Y.)|August 20, 2017
Cap-independent translation ensures mTOR expression and function upon protein synthesis inhibitionAna Marques-Ramos, Marco M Candeias, Juliane Menezes, et al.
Cellular and Molecular Life Sciences : CMLS|June 20, 2023
DIS3L2 knockdown impairs key oncogenic properties of colorectal cancer cells via the mTOR signaling pathwayJuan F García-Moreno, Rafaela Lacerda, Paulo J da Costa, et al.
International Journal of Molecular Sciences|December 23, 2022
Conserved Double Translation Initiation Site for Δ160p53 Protein Hints at Isoform's Key Role in Mammalian PhysiologyMaria José López-Iniesta, Shrutee N Parkar, Ana Catarina Ramalho, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 11, 2018
Genetics of personalized medicine: cancer and rare diseasesInês Teles Siefers Alves, Manuel Condinho, Sónia Custódio, et al.
Frontiers in Toxicology|May 4, 2026
New approach methodologies (NAMs) to support regulatory assessment of developmental immunotoxicity - a new PARC projectNicola M Smith, Véronique M P de Bruijn, Rob J Vandebriel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biomedicines|August 26, 2022
Internal Ribosome Entry Site (IRES)-Mediated Translation and Its Potential for Novel mRNA-Based Therapy DevelopmentRita Marques, Rafaela Lacerda, Luísa Romão
Journal of Molecular Biology|July 13, 2026
DIS3L2 and nonsense-mediated decay: united to degradeRafaela Lacerda, Miguel Carvalho, Luísa Romão
Cellular and Molecular Life Sciences : CMLS|December 4, 2016
More than just scanning: the importance of cap-independent mRNA translation initiation for cellular stress response and cancerRafaela Lacerda, Juliane Menezes, Luísa Romão
Advances in Experimental Medicine and Biology|July 26, 2019
Alternative Mechanisms of mRNA Translation Initiation in Cellular Stress Response and CancerRafaela Lacerda, Juliane Menezes, Marco M Candeias
RNA Biology|November 4, 2017
eIF3: a factor for human health and diseaseAndreia Gomes-Duarte, Rafaela Lacerda, Juliane Menezes, et al.
RNA (New York, N.Y.)|August 20, 2017
Cap-independent translation ensures mTOR expression and function upon protein synthesis inhibitionAna Marques-Ramos, Marco M Candeias, Juliane Menezes, et al.
Cellular and Molecular Life Sciences : CMLS|June 20, 2023
DIS3L2 knockdown impairs key oncogenic properties of colorectal cancer cells via the mTOR signaling pathwayJuan F García-Moreno, Rafaela Lacerda, Paulo J da Costa, et al.
International Journal of Molecular Sciences|December 23, 2022
Conserved Double Translation Initiation Site for Δ160p53 Protein Hints at Isoform's Key Role in Mammalian PhysiologyMaria José López-Iniesta, Shrutee N Parkar, Ana Catarina Ramalho, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 11, 2018
Genetics of personalized medicine: cancer and rare diseasesInês Teles Siefers Alves, Manuel Condinho, Sónia Custódio, et al.
Frontiers in Toxicology|May 4, 2026
New approach methodologies (NAMs) to support regulatory assessment of developmental immunotoxicity - a new PARC projectNicola M Smith, Véronique M P de Bruijn, Rob J Vandebriel, et al.
Pageof 1